FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activationRuiqi Zhu, Donald Small|Signal Transduction and Targeted Therapy|2021Cited by 106